Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 34 results.
User Information
Export Records
  1. 1.   A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib
  2. Curlee, Millicent S; Toledo-Tamula, Mary Anne; Baker, Melissa; Wikstrom, Daniel; Harrison, Cynthia; Rhodes, Amanda; Fagan, Margaret; Tibery,Cecilia; Wolters, Pamela L; Widemann, Brigitte C; Gross, Andrea M; Martin, Staci
  3. Cancers. 2025, Jan 17; 17(2):
  1. 2.   Imaging the cellular response to an antigen tagged interstrand crosslinking agent
  2. Bellani, Marina A; Huang, Jing; Zhang, Jing; Gali,Himabindu; Thazhathveetil, Arun Kalliat; Pokharel, Durga; Majumdar, Ishani; Shaik, Althaf; Seidman, Michael M
  3. DNA Repair. 2023, Jun 09; 128: 103525.
  1. 3.   The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps
  2. Crozier,Ian; Britson, Kyla A; Wolfe, Daniel N; Klena, John D; Hensley, Lisa E; Lee, John S; Wolfraim, Larry A; Taylor, Kimberly L; Higgs, Elizabeth S; Montgomery, Joel M; Martins, Karen A
  3. Vaccines. 2022, Jul 29; 10(8):
  1. 4.   Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses
  2. Milligan, Jacob C; Davis, Carl W; Yu, Xiaoying; Ilinykh, Philipp A; Huang, Kai; Halfmann, Peter J; Cross, Robert W; Borisevich, Viktoriya; Agans, Krystle N; Geisbert, Joan B; Chennareddy, Chakravarthy; Goff, Arthur J; Piper, Ashley E; Hui, Sean; Shaffer, Kelly C L; Buck, Tierra; Heinrich, Megan L; Branco, Luis M; Crozier,Ian; Holbrook, Michael R; Kuhn, Jens H; Kawaoka, Yoshihiro; Glass, Pamela J; Bukreyev, Alexander; Geisbert, Thomas W; Worwa, Gabriella; Ahmed, Rafi; Saphire, Erica Ollmann
  3. Cell. 2022, Mar 17; 185(6): 995-1007.e18.
  1. 5.   The importance of nanoparticle physicochemical characterization for immunology research: What we learned and what we still need to understand
  2. Clogston, Jeffrey D.
  3. Advanced Drug Delivery Reviews. 2021, Sep; 176
  1. 6.   TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository
  2. Zhao, Yingdong; Li, Ming-Chung; Konaté, Mariam M; Chen,Li; Das,Biswajit; Karlovich,Chris; Williams,Mickey; Evrard,Yvonne; Doroshow, James H; McShane, Lisa M
  3. Journal of translational medicine. 2021, Jun 22; 19(1): 269.
  1. 7.   C/EBPd protects from radiation-induced intestinal injury and sepsis by suppression of inflammatory and nitrosative stress
  2. Banerjee, Sudip; Fu, Qiang; Shah, Sumit K; Melnyk, Stepan B; Sterneck,Esta; Hauer-Jensen, Martin; Pawar, Snehalata A
  3. Scientific reports. 2019, Sep 27; 9(1): 13953.
  1. 8.   Design and performance of the micro-dose calibrator
  2. Adler, Stephen; Choyke, Peter
  3. Physics in Medicine and Biology. 2018, Sep 10; 63(18):
  1. 9.   Acute Retroviral Syndrome is Associated with High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments
  2. Crowell, Trevor A; Colby, Donn J; Pinyakorn, Suteeraporn; Fletcher, James L K; Kroon, Eugène; Schuetz, Alexandra; Krebs, Shelly J; Slike, Bonnie M; Leyre, Louise; Chomont, Nicolas; Jagodzinski, Linda L; Sereti, Irini; Utay, Netanya S; Dewar, Robin; Rerknimitr, Rungsun; Chomchey, Nitiya; Trichavaroj, Rapee; Valcour, Victor G; Spudich, Serena; Michael, Nelson L; Robb, Merlin L; Phanuphak, Nittaya; Ananworanich, Jintanat
  3. Clinical Infectious Diseases. 2018, May 15; 66(10): 1540-1549.
  1. 10.   A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals
  2. Cockerham, Leslie R; Yukl, Steven A; Harvill, Kara; Somsouk, Ma; Joshi, Sunil K; Sinclair, Elizabeth; Liegler, Teri; Hoh, Rebecca; Lyons, Sophie; Hunt, Peter W; Rupert, Adam; Sereti, Irini; Morcock, David; Rhodes, Ajantha; Emson, Claire; Hellerstein, Marc K; Estes, Jake; Lewin, Sharon; Deeks, Steven G; Hatano, Hiroyu
  3. Pathogens & Immunity. 2017 2(3): 310-334.
  1. 11.   Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation
  2. Crowell, T. A.; Fletcher, J. L.; Sereti, I.; Pinyakorn, S.; Dewar, R.; Krebs, S. J.; Chomchey, N.; Rerknimitr, R.; Schuetz, A.; Michael, N. L.; Phanuphak, N.; Chomont, N.; Ananworanich, J.
  3. Journal of the International Aids Society. 2016 19(1): 21163.
  1. 12.   The Role of Worksite and Home Smoking Bans in Smoking Cessation Among US Employed Adult Female Smokers
  2. Rose, A.; Fagan, P.; Lawrence, D.; Hart, A.; Shavers, V. L.; Gibson, J. T.
  3. American Journal of Health Promotion. 2011, Sep-Oct; 26(1): 26-36.
  1. 13.   Host genes associated with HIV/AIDS: advances in gene discovery
  2. An, P.; Winkler, C. A.
  3. Trends in Genetics. 2010, Mar; 26(3): 119-131.
  1. 14.   Multistage Genomewide Association Study Identifies a Locus at 1q41 Associated with Rate of HIV-1 Disease Progression to Clinical AIDS
  2. Herbeck, J. T.; Gottlieb, G. S.; Winkler, C. A.; Nelson, G. W.; An, P.; Maust, B. S.; Wong, K. G.; Troyer, J. L.; Goedert, J. J.; Kessing, B. D.; Detels, R.; Wolinsky, S. M.; Martinson, J.; Buchbinder, S.; Kirk, G. D.; Jacobson, L. P.; Margolick, J. B.; Kaslow, R. A.; O'Brien, S. J.; Mullins, J. I.
  3. Journal of Infectious Diseases. 2010, Feb; 201(4): 618-626.
  1. 15.   Syphilis co-infection does not affect HIV disease progression
  2. Weintrob, A. C.; Gu, W.; Qin, J.; Robertson, J.; Ganeson, A.; Crum-Cianflone, N. F.; Landrum, M. L.; Wortmann, G. W.; Foliman, D.; Agan, B. K.
  3. International Journal of Std & Aids. 2010, Jan; 21(1): 57-59.
  1. 16.   Serotype-selective, small-molecule inhibitors of the zinc endopeptidase of botulinum neurotoxin serotype A
  2. Park, J. G.; Sill, P. C.; Makiyi, E. F.; Garcia-Sosa, A. T.; Millard, C. B.; Schmidt, J. J.; Pang, Y. P.
  3. Bioorganic & Medicinal Chemistry. 2006, Jan; 14(2): 395-408.
  1. 17.   Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression
  2. Daar, E. S.; Lynn, H. S.; Donfield, S. M.; Lail, A.; O'Brien, S. J.; Huang, W.; Winkler, C. A.
  3. Journal of Infectious Diseases. 2005, NOV 1; 192(9): 1597-1605.
  1. 18.   Hematotoxicity in workers exposed to low levels of benzene
  2. Lan, Q.; Zhang, L. P.; Li, G. L.; Vermeulen, R.; Weinberg, R. S.; Dosemeci, M.; Rappaport, S. M.; Shen, M.; Alter, B. P.; Wu, Y. J.; Kopp, W.; Waidyanatha, S.; Rabkin, C.; Guo, W. H.; Chanock, S.; Hayes, R. B.; Linet, M.; Kim, S.; Yin, S. N.; Rothman, N.; Smith, M. T.
  3. Science. 2004, DEC 3; 306(5702): 1774-1776.
  1. 19.   Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression
  2. Winkler, C. A.; Hendel, H.; Carrington, M.; Smith, M. W.; Nelson, G. W.; O'Brien, S. J.; Phair, J.; Vlahov, D.; Jacobson, L. P.; Rappaport, J.; Vasilescu, A.; Bertin-Maghit, S.; An, P.; Lu, W.; Andrieu, J. M.; Schachter, F.; Therwath, A.; Zagury, J. F.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2004, DEC 1; 37(4): 1534-1538.
  1. 20.   Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles
  2. Mossman, S. P.; Pierce, C. C.; Watson, A. J.; Robertson, M. N.; Montefiori, D. C.; Kuller, L.; Richardson, B. A.; Bradshaw, J. D.; Munn, R. J.; Hu, S. L.; Greenberg, P. D.; Benveniste, R. E.; Haigwood, N. L.
  3. Aids Research and Human Retroviruses. 2004 20(4): 425-434.
  1. 21.   A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus
  2. Tavel, J. A.; Sereti, I.; Walker, R. E.; Hahn, B.; Kovacs, J. A.; Jagannatha, S.; Davey, R. T.; Falloon, J.; Polis, M. A.; Masur, H.; Metcalf, J. A.; Stevens, R.; Rupert, A.; Baseler, M.; Lane, H. C.
  3. Journal of Infectious Diseases. 2003 188(4): 531-536.
  1. 22.   A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4(+) T cell depletion in human immunodeficiency virus-1-infected individuals
  2. An, P.; Vlahov, D.; Margolick, J. B.; Phair, J.; O'Brien, T. R.; Lautenberger, J.; O'Brien, S. J.; Winkler, C. A.
  3. Journal of Infectious Diseases. 2003 188(2): 228-231.
  1. 23.   Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions
  2. Zhu, P.; Chertova, E.; Bess, J.; Lifson, J. D.; Arthur, L. O.; Liu, J.; Taylor, K. A.; Roux, K. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2003 100(26): 15812-15817.
  1. 24.   Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study
  2. Yamashita, T. E.; Phair, J. P.; Munoz, A.; Margolick, J. B.; Detels, R.; O'Brien, S. J.; Mellors, J. W.; Wolinsky, S. M.; Jacobson, L. P.
  3. Aids. 2001 15(6): 735-746.
  1. 25.   Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy
  2. Polis, M. A.; Sidorov, I. A.; Yoder, C.; Jankelevich, S.; Metcalf, J.; Mueller, B. U.; Dimitrov, M. A.; Pizzo, P.; Yarchoan, R.; Dimitrov, D. S.
  3. Lancet. 2001 358(9295): 1760-1765.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel